Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Bulletin Du Cancer|May 16, 2019
[Stage 1 germ-cell tumour]Sara Faouzi, Siham Ouguellit, Yohann LoriotNature Reviews. Clinical Oncology|October 7, 2022
The multiple roles of LDH in cancerGiuseppina Claps, Sara Faouzi, Virginie Quidville, et al.Bulletin Du Cancer|August 23, 2017
[What biomarkers for the future? The point of view of the residents in oncology after the ESMO 2016 Congress]Marie Auvray, Marc-Antoine Benderra, Marie Bretagne, et al.Cell Reports|November 25, 2020
Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid OxidationShensi Shen, Sara Faouzi, Sylvie Souquere, et al.Computational and Structural Biotechnology Journal|February 15, 2023
Spatial patterns of the cap-binding complex eIF4F in human melanoma cellsXinpu Tang, Yi Pu, Haoning Peng, et al.Targeted Oncology|June 5, 2021
Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter StudyAlmudena Callejo, Sara Faouzi, Olivier Bouché, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic MelanomaIsabelle Girault, Julien Adam, Shensi Shen, et al.Nature Communications|December 18, 2019
An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cellsShensi Shen, Sara Faouzi, Amandine Bastide, et al.Pageof 1